All Posts By

admin

The Richard Williams Memorial Award

By | Awards, Meetings | No Comments

The IGG are proud to support an award honouring the scientific contributions and memory of Dr. Richard Williams, set up by Lhasa. This award will support early career investigators within industry. The Richard Williams Memorial Award will sponsor one individual a year to attend and present at the United Kingdom Environmental Mutagen Society (UKEMS) meeting.

Rich believed that a key part of his role in industry was to support others; to help others deliver and become better at their role. Both the IGG and Lhasa Limited felt it greatly appropriate to honour Rich with an award in his memory that would give early career investigators, be they students or working within industry, a wonderful opportunity to present their work at the annual UKEMS meeting.

The IGG committee will select 3-4 abstracts from all entries to give a short presentation at the IGG virtual meeting this year (30th November – 1st December). The presentations will be judged and voted on by either the IGG committee or the meeting attendees. The Richard Williams Memorial Award will include a certificate, travel, registration and accommodation expenses for attendance to the UKEMS meeting at which the award winner will have the amazing opportunity of presenting their work.

Lhasa Limited and the IGG committee are asking people to share this message with colleagues and encourage all eligible young scientists to put themselves forward for this award. To apply, please send a title and abstract (max 300 words) to the IGG Committee by 30th September 2020.

You can find out more about Rich and the award here.

Job Vacancies: Opportunities at Gentronix

By | Job advert | No Comments

Gentronix have job vacancies!

Gentronix are looking for study directors, scientists and study investigators to support continued growth in their genetic toxicology testing team at Alderley Park in Cheshire.

Gentronix are a leading specialist predictive toxicology contract research organisation, focusing on genetic toxicology and skin toxicity.

For more information on these vacancies click here or email: info@gentronix.co.uk.

Save the Date for the IGG Annual Meeting 2020!

By | Uncategorized | No Comments

‘Save the Date’ for the IGG Annual Meeting!

The IGG Annual meeting will be held on November 30th – December 1st 2020.

The meeting will have the theme ‘New ways with old data’, and talks will cover new technologies for genetic toxicology and new data analysis methods. Also, for the first time, this year we will host a New Investigator Session with an award for the best talk. For more information, see the flyer. Updates will follow soon. To stay up to date check our website where you can also join our mailing list, follow us on Twitter, and join our LinkedIn group.

NUKEMS Committee member vacancy

By | Uncategorized | No Comments

NUKEMS are looking for new committee members!

NUKEMS aims to actively represent New Investigators within UKEMS and its linked societies. Its committee is made up of both academic and industrial scientists with less than 4 years post-doctoral, post-graduate or industrial experience. NUKEMS aims to be innovative in supporting, enthusing, educating and recruiting young scientists, and to play a major role in organising the Sunday session of the UKEMS Annual Conference, which is traditionally run as an Educational Session aimed at young scientists. NUKEMS also aims to enhance the online presence of UKEMS via the website and social media platforms.

Please see the flyer for more information.

If you interested in joining the NUKEMS Committee or have any questions please contact Fiona Chapman.

Genetic Toxicologist Vacancy at AstraZeneca – Deadline Extended!

By | Uncategorized | No Comments

Do you have a primary focus on toxicology science with a working knowledge and experience of drug development?

An exciting opportunity exists to join the Genetic Toxicology Team in Cambridge to support the development of innovative drugs and improve patients’ lives.

The group is part of Functional and Mechanistic Safety, which is a global department that is part of the Clinical Pharmacology and Safety Sciences (CPSS) function & applies innovative science to drive the design, selection and development of safer medicines. The Functional and Mechanistic Safety group work collaboratively delivering safety science from early discovery through clinical development.

For more information and to apply, click here.

Job Reference: R-075502

Closing date: 16th April 2020

Duplex Sequencing Webinar

By | Webinar | No Comments

Working from home? Keep up to date with the latest sequencing technology for mutation detection by joining a webinar on Thursday March 26th on Duplex Sequencing. To register, click here.

Title: Duplex Sequencing™ Technology: Transforming Safety Testing

Date: Thursday, March 26, 2020

Time: 11:00 AM Eastern Daylight Time

Duration: 1 hour

Speakers:

Bob Young, MS
Program Consultant and Study Director, In Vivo Mutation
Merck KGaA, Darmstadt, Germany

Jesse Salk, MD, PhD
CEL, CSO and Founder
TwinStrand Biosciences

In this webinar, you will learn about:

  • Duplex Sequencing™ technology unmatched sensitivity and accuracy in NGS applications
  • Duplex technology applications in identification of carcinogenic chemicals
  • Global efforts to evaluate and adopt Duplex Sequencing™ technology for regulatory submission
  • Applications in drug and chemical safety assessment

Detailed description:

Duplex Sequencing™ technology is a new error-corrected NGS method that improves sequencing accuracy 100,000-fold. This increase in accuracy opens the door to significant reductions in time spent in drug development, allowing measurement of a compound’s carcinogenic risk months or even years earlier than current methods. DS technology now permits early measurement of ultra-rare new mutants. We will discuss the technology, clinical applications and then explore nonclinical safety assessment applications. Mouse and rat mutation data will be presented from various mutagens, tissues and genes. Mutant frequency data and mutational “fingerprint” data will be discussed in context of human tumors. Plans for collaborative qualification through the HESI Genetic Toxicology Technical Committee will be discussed.

Job vacancy at AstraZeneca – Genetic Toxicologist

By | Job advert | No Comments

Do you have a primary focus on toxicology science with a working knowledge and experience of drug development?

An exciting opportunity exists to join the Genetic Toxicology Team in Cambridge to support the development of innovative drugs and improve patients’ lives.

The group is part of Functional and Mechanistic Safety, which is a global department that is part of the Clinical Pharmacology and Safety Sciences (CPSS) function & applies innovative science to drive the design, selection and development of safer medicines. The Functional and Mechanistic Safety group work collaboratively delivering safety science from early discovery through clinical development.

For more information and to apply, click here.

Job Reference: R-075545

Closing date: 24th March 2020

 

EEMGS Abstract Deadline – Jan 31st

By | Meetings | No Comments

Mark your presence on the 48th European Environmental Mutagenesis and Genomics Society Annual Meeting (EEMGS2020) to be held in Porto, Portugal, between 6 – 8 May 2020, by submitting your abstract now!

There are only a few days left until the deadline of 31st January 2020. Do not miss out the opportunity to share your work with peers from industry, universities and regulatory bodies from all around the world. Submit your abstract here: https://www.eemgs2020.eu/en/registration/submissions/

The general theme of the congress is “Exposure and Susceptibility: bridging gaps to improve health”. The preliminary Scientific Programme is now available on their website: www.eemgs2020.eu

Gentronix Job Vacancy: In vitro mammalian gene mutation Study Director

By | Job advert | No Comments

Job vacancy at Gentronix for an in vitro mammalian gene mutation Study Director

Job Reference: GTXHPRT2020 

Opening Date – 10th January 2020
Closing Date – 10th February 2020

Gentronix is seeking an enthusiastic and highly motivated scientist to join our in vitro genetic toxicology team as an in vitro mammalian gene mutation Study Director. The team is growing due to planned services expansion and needs a committed and organised individual to help drive the expansion of the in vitro genetic toxicology service offering. The role will require good integration into the existing team and close working with the other Study Directors. For the successful applicant, the role presents opportunities to build-on and further develop their skills as a toxicologist within a CRO environment, with scope for further career progression within a growing and successful business.

For full job specifications and how to apply, click here.

Call for IGG Ordinary Committee Member

By | Uncategorized | No Comments

A position is available for an ordinary committee member of the Industrial Genotoxicity Group (IGG).  Committee members will be involved in setup of IGG meetings and also initiatives that of benefit to our members.

If you are interested in joining the committee, or have any questions, please contact Paul Rawlinson, the IGG Committee secretary (paul.rawlinson@gentronix.co.uk).

The deadline for putting yourself forward is the end of November.